Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Nov 8, 2025

Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines
09:45

Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines

Published on: August 21, 2019

7.3K

[Small Cell Lung Cancer].

N Reinmuth, H Hoffmann

    Pneumologie (Stuttgart, Germany)
    |April 19, 2021
    PubMed
    Summary
    This summary is machine-generated.

    Small cell lung cancer is aggressive and progresses rapidly. While immunotherapy has recently advanced treatment, new therapies are under investigation to improve outcomes for patients with metastatic disease.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Quantification of dissolved organic carbon at very low levels in natural ice samples by a UV-induced oxidation method.

    Environmental science & technology·2010
    Same author

    The solubilisation of a water insoluble functionalized silicone oil in an aqueous surfactant solution: a novel mechanism for the solubilisation process.

    Journal of colloid and interface science·2010
    Same author

    [S100 protein positive sustentacular cells in pulmonary carcinoids and thoracic paragangliomas: differential diagnostic and prognostic evaluation].

    Der Pathologe·2010
    Same author

    Antibodies to aquaporin-4 in non-small cell lung cancer: a study on 50 patients.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2010
    Same author

    Deposition and metabolism of inhaled ciclesonide in the human lung.

    The European respiratory journal·2010
    Same author

    [fs-Lentotomy: presbyopia reversal by generating gliding planes inside the crystalline lens].

    Klinische Monatsblatter fur Augenheilkunde·2010
    Same journal

    Pneumologie (Stuttgart, Germany)·2026
    Same journal

    Aerosol therapy during noninvasive ventilation (NIV) and nasal high-flow therapy (HFT): current technology and consensus-based recommendations.

    Pneumologie (Stuttgart, Germany)·2026
    Same journal

    [Correction: Pharmacotherapy for Tobacco Dependence: Implementation of the Current G-BA Resolution - Erratum: Information from Section E3 of the DGP regarding the G-BA Resolution].

    Pneumologie (Stuttgart, Germany)·2026
    Same journal

    [Pharmacotherapy for Tobacco Dependence: Implementation of the Current G-BA Resolution - Information from Section E3 of the DGP regarding the G-BA Resolution].

    Pneumologie (Stuttgart, Germany)·2026
    Same journal

    [Acute lung failure].

    Pneumologie (Stuttgart, Germany)·2026
    Same journal

    [The internet as a source of information for patients with sarcoidosis].

    Pneumologie (Stuttgart, Germany)·2026
    See all related articles

    Area of Science:

    • Oncology
    • Pulmonology
    • Cancer Research

    Background:

    • Small cell lung cancer (SCLC) is a highly aggressive malignancy.
    • Characterized by rapid progression, early metastasis, and poor prognosis.
    • Limited treatment options exist for patients with metastatic disease.

    Purpose of the Study:

    • To review the current systemic treatment landscape for small cell lung cancer.
    • To highlight recent advancements, including immunotherapy.
    • To discuss emerging therapeutic strategies for future treatment.

    Main Methods:

    • Literature review of current and emerging treatments for SCLC.
    • Analysis of systemic therapy efficacy in metastatic SCLC.
    • Overview of clinical trials for novel SCLC therapies.

    More Related Videos

    Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
    07:59

    Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

    Published on: September 8, 2023

    1.4K

    Related Experiment Videos

    Last Updated: Nov 8, 2025

    Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines
    09:45

    Radiosensitivity of Cancer Stem Cells in Lung Cancer Cell Lines

    Published on: August 21, 2019

    7.3K
    Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
    07:59

    Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

    Published on: September 8, 2023

    1.4K

    Main Results:

    • Platinum doublet chemotherapy is a standard first-line treatment but resistance is common.
    • Immunotherapy has recently been incorporated, offering new hope.
    • Numerous novel agents and immune strategies are in clinical development.

    Conclusions:

    • Systemic therapy is critical for most SCLC patients, especially those with metastatic disease.
    • Recent integration of immunotherapy marks a significant advancement.
    • Ongoing research into new cytotoxic agents and immune modulatory strategies promises to expand future treatment options.